Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Year: 2008
Type: article
Abstract: D iabetes is defined by its associationwith hyperglycemia-specific micro-vascular complications; however, it also imparts a two- to fourfold risk of car-diovascular disease (CVD). Although mi-crovascular complications can lead to significantmorbidity and prematuremor-tality, by far the greatest cause of death in people with diabetes is CVD. Results from randomized controlled trials have demonstrated conclusively that the risk of microvascular complica-tions can be reduced by intensive glyce-mic control in patients with type 1 (1,2) and type 2 diabetes (3–5). In the Diabe-tes Control and Complications Trial (DCCT), there was an60 % reduction in
Source: Diabetes Care
DOI: 10.2337/dc08-9026
Institutions: University of Miami, Park Nicollet Clinic, Northwestern University, University of North Carolina at Chapel Hill, University of California, San Francisco, VA Central California Health Care System, University of Bristol, MedStar Health Research Institute, American Diabetes Association, Saint Luke's Hospital, University of Missouri–Kansas City, Carl T. Hayden Veterans Affairs Medical Center, Yale University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2181092548
